The UK is the first country to grant emergency approval to Pfizer and BioNTech’s Covid-19 vaccine
The United Kingdom on Wednesday granted temporary authorization for emergency use of the Covid-19 vaccine developed by Pfizer and BioNTech to adults age 16 and older, with the first 800,000 doses of the two-dose vaccine slated to be offered in the country next week. This makes the UK the first country to approve the Pfizer/BioNTech…